We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
+4.27%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$87.2B
AUM Growth
+$48.6B
(+126%)
Cap. Flow
+$45.9B
Cap. Flow
% of AUM
52.69%
Top 10 Holdings %
Top 10 Hldgs %
30.85%
Holding
2,321
New
462
Increased
1,622
Reduced
136
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.85B |
| 2 |
NVIDIA
NVDA
|
+$2.64B |
| 3 |
Apple
AAPL
|
+$2.26B |
| 4 |
Amazon
AMZN
|
+$1.54B |
| 5 |
Meta Platforms (Facebook)
META
|
+$940M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$196M |
| 2 |
Ciena
CIEN
|
+$103M |
| 3 |
HOLX
Hologic
HOLX
|
+$76.8M |
| 4 |
Albemarle
ALB
|
+$61.5M |
| 5 |
First Solar
FSLR
|
+$47.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.28% |
| 2 | Healthcare | 12.94% |
| 3 | Financials | 10.66% |
| 4 | Consumer Discretionary | 10.56% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Evolent Health
EVH
$471M
| $7K | ﹤0.01% |
+1,768
| New | +$9.83K |
|
2152
HealthStream
HSTM
$829M
| $7K | ﹤0.01% |
323
+110
| +52% | +$2.77K |
|
2153
i3 Verticals
IIIV
$323M
| $7K | ﹤0.01% |
+269
| New | +$7.57K |
|
2154
Janux Therapeutics
JANX
$1.02B
| $7K | ﹤0.01% |
508
+137
| +37% | +$3.22K |
|
2155
MiMedx Group
MDXG
$624M
| $7K | ﹤0.01% |
1,057
+304
| +40% | +$2.13K |
|
2156
Sinclair Inc
SBGI
$1B
| $7K | ﹤0.01% |
475
+139
| +41% | +$2.06K |
|
|
SKYT
2157
DELISTED
SkyWater Technology
SKYT
| $7K | ﹤0.01% |
+368
| New | +$6.39K |
|
2158
Shutterstock
SSTK
$208M
| $7K | ﹤0.01% |
+372
| New | +$7.95K |
|
2159
Petco
WOOF
$780M
| $7K | ﹤0.01% |
2,587
+997
| +63% | +$3.23K |
|
|
KLC
2160
KinderCare Learning Companies
KLC
$550M
| $7K | ﹤0.01% |
1,578
+840
| +114% | +$4.23K |
|
|
NAGE
2161
Niagen Bioscience
NAGE
$242M
| $7K | ﹤0.01% |
+1,097
| New | +$7.63K |
|
2162
Hovnanian Enterprises
HOV
$793M
| $6K | ﹤0.01% |
64
+29
| +83% | +$3.42K |
|
2163
Ramaco Resources Class A
METC
$692M
| $6K | ﹤0.01% |
327
+123
| +60% | +$3.23K |
|
2164
Vitamin Cottage Natural Grocers
NGVC
$632M
| $6K | ﹤0.01% |
243
+102
| +72% | +$3.27K |
|
2165
Sharplink Inc
SBET
$1.34B
| $6K | ﹤0.01% |
+679
| New | +$8.29K |
|
2166
SES AI
SES
$211M
| $6K | ﹤0.01% |
+3,540
| New | +$7.93K |
|
2167
UWM Holdings
UWMC
$2.42B
| $6K | ﹤0.01% |
1,474
+481
| +48% | +$2.59K |
|
2168
Ibotta
IBTA
$722M
| $6K | ﹤0.01% |
247
+17
| +7% | +$459 |
|
2169
Anavex Life Sciences
AVXL
$316M
| $5K | ﹤0.01% |
1,321
+412
| +45% | +$2.52K |
|
2170
Oric Pharmaceuticals
ORIC
$1.43B
| $5K | ﹤0.01% |
647
+99
| +18% | +$1.14K |
|
|
LENZ
2171
LENZ Therapeutics
LENZ
$158M
| $5K | ﹤0.01% |
312
+178
| +133% | +$5.19K |
|
|
ARDT
2172
Ardent Health
ARDT
$1.57B
| $5K | ﹤0.01% |
+571
| New | +$6.6K |
|
2173
Agilon Health
AGL
$1.45B
| – | – |
-205
| Closed | -$5K |
|
|
AKRO
2174
DELISTED
Akero Therapeutics
AKRO
| – | – |
-504
| Closed | -$24K |
|
2175
Arhaus
ARHS
$1.37B
| – | – |
-440
| Closed | -$5K |
|
Similar funds
BNP Paribas Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, BNP Paribas Asset Management held 2,321 positions worth $87.2B, up 126% from $38.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
BNP Paribas Asset Management deployed $45.9B of net new capital in Q4 2025, opening 462 new positions and adding to 1,622 existing holdings. Its largest new stake was Microsoft: 9,684,778 shares worth $4.68B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $196M trimmed.
- BNP Paribas Asset Management's largest Q4 2025 buy was Microsoft: 9,684,778 shares worth $4.68B.
- BNP Paribas Asset Management added most to NVIDIA in Q4 2025, an estimated $2.64B increase.
- BNP Paribas Asset Management's biggest Q4 2025 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $196M.
- BNP Paribas Asset Management fully exited Kellanova in Q4 2025, selling an estimated $15.7M.
- BNP Paribas Asset Management's ten largest holdings make up 31% of its $87.2B portfolio in Q4 2025.
- BNP Paribas Asset Management opened 462 new positions and closed 56 in Q4 2025.
- BNP Paribas Asset Management's portfolio value rose 126% quarter-over-quarter to $87.2B.
Based on BNP Paribas Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.